CDC study shows emergency department visits also on the rise among women

Deaths from Prescription Painkiller Overdoses Rise Sharply Among Women

 

Atlanta, GA, USA (July 2, 2013) – The number of prescription painkiller overdose deaths increased five fold among women between 1999 and 2010, according to a Vital Signs report released today by the Centers for Disease Control and Prevention. While men are more likely to die of a prescription painkiller overdose, since 1999 the percentage increase in deaths was greater among women (400 percent in women compared to 265 percent in men). Prescription painkiller overdoses killed nearly 48,000 women between 1999 and 2010.

 

“Prescription painkiller deaths have skyrocketed in women (6,600 in 2010), four times as many as died from cocaine and heroin combined,” said CDC Director Tom Frieden, M.D., M.P.H.  “Stopping this epidemic in women – and men – is everyone’s business. Doctors need to be cautious about prescribing and patients about using these drugs.”

 

The study includes emergency department visits and deaths related to drug misuse/abuse and overdose, as well as analyses specific to prescription painkillers. The key findings include:

 

  • About 42 women die every day from a drug overdose.

 

      • Since 2007, more women have died from drug overdoses than from motor vehicle crashes.
      • Drug overdose suicide deaths accounted for 34 percent of all suicides among women compared with 8 percent among men in 2010.
      • More than 940,000 women were seen in emergency departments for drug misuse or abuse in 2010.

 

  • Prescription painkillers have been a major contributor to increases in drug overdose deaths among women.

 

      • More than 6,600 women, or 18 women every day, died from a prescription painkiller overdose in 2010.
      • There were four times more deaths among women from prescription painkiller overdose than for cocaine and heroin deaths combined in 2010.
      • In 2010, there were more than 200,000 emergency department visits for opioid misuse or abuse among women; about one every three minutes.

 

For the Vital Signs report, CDC analyzed data from the National Vital Statistics System (1999-2010) and the Drug Abuse Warning Network public use file (2004-2010).

 

Previous research has shown that women are more likely to have chronic pain, be prescribed prescription painkillers, be given higher doses, and use them for longer time periods than men. Studies have also shown that women may become dependent on prescription painkillers more quickly than men and may be more likely than men to engage in “doctor shopping” (obtaining prescriptions from multiple prescribers).

 

“The prescription painkiller problem affects women in different ways than men and all health care providers treating women should be aware of this,” said Linda C. Degutis, Dr.P.H., M.S.N., director of CDC′s National Center for Injury Prevention and Control. “Health care providers can help improve the way painkillers are prescribed while making sure women have access to safe and effective pain treatment.”

 

Steps that health care providers can take when treating women include:

 

  • Following guidelines for responsible opioid prescribing, including screening and monitoring for substance abuse and mental health problems.
  • Using their states’ prescription drug monitoring program; this can help identify patients who may be improperly using opioids and other drugs.
  • Discussing pain treatment options, including ones that do not involve prescription drugs.
  • Discussing the risks and benefits of taking prescription painkillers including when painkillers are taken for chronic conditions, and especially during pregnancy.
  • Avoiding prescribing combinations of prescription painkillers and benzodiazepines unless there is a specific medical indication.

 

Women can take steps to help stay safe from prescription painkiller overdoses, including:

 

  • Using prescription drugs only as directed by a health care provider.
  • Discussing all medications they are taking with their health care provider, including over-the-counter medications (such as for allergies).
  • Discussing pregnancy plans with their health care provider before taking prescription painkillers.
  • Disposing of medications properly, as soon as the course of treatment is done. Not keeping prescription medications around “just in case.”
  • Helping prevent misuse and abuse by not selling or sharing prescription drugs. Never using another person’s prescription drugs.
  • Getting help for substance abuse problems (1-800-662-HELP) and calling Poison Help (1-800-222-1222) with questions about medicines.

 

CDC’s Injury Center works to protect the safety of everyone, every day. For more information about prescription drug overdoses, please visit www.cdc.gov/HomeandRecreationalSafety/Poisoning.

 

Vital Signs is a CDC report that appears on the first Tuesday of the month as part of the CDC journal Morbidity and Mortality Weekly Report, or MMWR. The report provides the latest data and information on key health indicators. These are cancer prevention, obesity, tobacco use, motor vehicle passenger safety, prescription drug overdose, HIV/AIDS, alcohol use, health care–associated infections, cardiovascular health, teen pregnancy, food safety and viral hepatitis.

 


Download

 


 

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

 


 

Centers for Disease Control and Prevention, 02.07.2013 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Toujeo® bei Typ-1-Diabetes: Weniger schwere Hypoglykämien und weniger Ketoazidosen 
Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung